PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34066057-5	2021	Modulation of their activity using PARP inhibitors occupying the NAD+ binding site has proven successful in cancer therapies.	NAD	65-69	poly(ADP-ribose) polymerase 1	Homo sapiens	35-39